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Background
Duchenne (DMD) and Becker (BMD) muscular dystro-
phies (MD) are allelic X-linked recessive disorders,
caused by mutation of the dystrophin gene located at
locus Xp21 that consists of 79 exons, characterized by
progressive skeletal muscle degeneration and replace-
ment by fibro fatty tissue. Dystrophin is a sarcolemal
protein that links the cytoskeleton to the basal lamina
and is essential for maintenance of the muscular mem-
brane integrity during muscular contraction. Cardiac
involvement is frequent, 70 - 80% of patients, and often
develops clinically silent, without any evident early clini-
cal signs. CMR can identify myocardial fibrosis (MF)
and may be useful for detecting the early stages of cardi-
omyopathy in MD. In a previous study, DNA analyses in
47 pts with DMD revealed significant association
between dilated cardiomyopathy (DCM) and specific
exons and possible protection against DCM by other
exons. The association between specific exons mutation
of the dystrophin gene and myocardial fibrosis is until
unknown.
Methods
We enrolled 76 pts, 70 pts DMD and 6 BMD with con-
firmed muscular dystrophy. Mean age was 13.1 ± 4.4
years. MLPA tests were performed on all these patients.
40 pts showed DNA mutation. According to specific
exons mutation, these patients were classified into 2
groups: with exons mutation below 45 and with muta-
tion on or above 45. All patients underwent CMR study
in a 1.5-T Siemens Avanto (Erlangen, Germany), using
cine resonance for function evaluation and myocardial
delayed enhancement (MDE) technique for myocardial
fibrosis detection, 10 min after intravenous bolus of 0.2
mmol/kg of gadolinium-based contrast. Cine and MDE
parameters were, respectively: TR 2.0/9.0, TE 1.07/5.0;
FA 69/50; cardiac phases 20/1; VPS 8/16 to 32; matrix
192 × 162/256 × 192; ST 8/8 mm; gap 2/2 and FOV 32-
38/32-38 cm; TI none/150-390 ms. Two experienced
observers measured LV volumes and ejection fraction by
the Simpson method (Argus software, Siemens). In the
MDE short axis images, we evaluated the MF mass per
patient, using a 5 standard deviation thresholding tech-
nique, on CMR42 software, version 3.4.2 (Circle Cardio-
vascular Imaging, Calgary, Alberta, Canada). Mann
Whitney was used for comparison of myocardial fibrosis
between the group with mutation in exons < 45 and
mutation in exons ≥45.
Results
Of the 40 pts with DNA mutation, 16 pts showed muta-
tion below exon 45 and 25 pts in exons on or above 45.
The specific mutations were shown to be associated with
cardiac involvement (myocardial fibrosis). Patients with
mutations in exons less than 45 had greater extent of
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myocardial fibrosis than patients with mutations in exons
greater than or equal to 45 in CMR at baseline (27.9 ±
18.4% vs. 12.1 ± 13.4%, respectively, p = 0.006) and at fol-
low-up (33.1 ± 21.1% vs. 18.8 ± 16.9%, respectively, p =
0.024).
Conclusions
There was a significant correlation between the site of
mutation in the dystrophin gene and myocardial fibrosis.
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Figure 1 Myocardial fibrosis quantification in DMD and BMD
patients with mutation in exons ≥ 45 and < 45. Fib% -
myocardial fibrosis as percent of LV mass Fib g - myocardial fibrosis
in grams Fib ml - myocardial fibrosis volume in milliliters No. seg.
fib - number of AHA segments with fibrosis.
Silva et al. Journal of Cardiovascular Magnetic
Resonance 2014, 16(Suppl 1):P325
http://www.jcmr-online.com/content/16/S1/P325
Page 2 of 2
